Stearylated KALA (STR-KALA) on MITO-Porter surface (10 mol% of total lipids); cationic amphipathic CPP; plus Cholesterol-linked RNase P (RP) mitochondrial RNA aptamer (Chol-RP) added to surface (typically 4 mol% of total lipids) to enhance uptake/mitochondrial targeting